-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
Shijiazhuang Sihua Pharmaceutical Group: “Spring Breeze” Helps Enterprises Move Toward Innovation and Excellence
Category:
发布时间：2026-02-25
【概要描述】
On February 24, researchers at the Pharmaceutical Research Institute of Shijiazhuang Sihua Pharmaceutical Group were stepping up experimental work on the development of new products.
A plan for the year begins in spring.
On February 24, researchers at the Pharmaceutical Research Institute of Shijiazhuang Sihua Pharmaceutical Group were intensifying experimental work on the development of new products.
On the occasion of the Spring Festival work resumption, Shijiazhuang Sihua Pharmaceutical Group is leveraging the momentum of the province-wide conference on optimizing the business environment to fully capitalize on targeted policies designed to benefit enterprises—such as the pre-approval service for the additional deduction of R&D expenses—and to harness a favorable business climate. With innovation-driven development at its core, the company is actively implementing a pharmaceutical revitalization initiative, accelerating its transformation toward the R&D of innovative drugs, high-end complex formulations, and active pharmaceutical ingredients, thereby continuously promoting high-quality corporate growth and striving to make a greater contribution to the high-quality development of the pharmaceutical industry in Shijiazhuang and Hebei Province.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091